SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-045144
Filing Date
2021-02-16
Accepted
2021-02-16 17:01:54
Documents
1
Group Members
BLACKSTONE CLARUS GP L.L.C.BLACKSTONE CLARUS GP L.P.BLACKSTONE GROUP INC.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS II L.P.CLARUS IV GP, L.P.CLARUS IV-A, L.P.CLARUS IV-B, L.P.CLARUS IV-C, L.P.CLARUS IV-D, L.P.STEPHEN A. SCHWARZMAN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d121358dsc13ga.htm SC 13G/A 212785
  Complete submission text file 0001193125-21-045144.txt   214834
Mailing Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154 2125835000
Blackstone Holdings I/II GP L.L.C. (Filed by) CIK: 0001464695 (see all company filings)

IRS No.: 260238303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91201 | Film No.: 21640493
SIC: 2834 Pharmaceutical Preparations